Skip to content
Buy This GLP
← Research
Evidence

SURMOUNT-5 Lifetime Cost Model: Tirzepatide Dominant Over Semaglutide

Using SURMOUNT-5 data, a U.S. model projected lower lifetime societal costs and more quality-adjusted years with tirzepatide than with semaglutide.

Editorial profile: Carla MedinaBuy This GLP Editorial Team6 min read
Modeled lifetime differences vs semaglutide$41,688 lower societal costs per patient0.506 more quality-adjusted life years

A comparison of treatment cost and benefit depends on the period and whose costs are counted. This simulation used data from the SURMOUNT-5 trial to project lifetime results from a U.S. societal perspective [1].

What the model projected

Compared with semaglutide, tirzepatide was projected to cost $41,688 less per person and yield 0.506 additional quality-adjusted life years. The model also projected 70 fewer cases of type 2 diabetes and 10 fewer cardiovascular disease cases per 1,000 patients [1].

The model used changes in weight and other risk factors to estimate later outcomes. It counted health care and wider societal costs, including lost productivity. The trial did not observe those lifetime outcomes.

Why assumptions and perspective matter

Research on how long people stay on GLP-1 treatment shows why results from one care setting may be difficult to carry over to another. The lifetime estimates depend on the model's treatment, cost and risk assumptions.

The study includes authors affiliated with Eli Lilly, which makes tirzepatide. The projected difference in societal costs cannot be used as an individual prescription quote.

Frequently asked

Did the trial observe $41,688 in lifetime savings?
That figure came from a simulation using trial inputs. It represents projected societal costs rather than a bill or observed lifetime spending.

Sources

  1. [1] Johansson E, et al. (2026). Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial Journal of Medical Economics. PMID 42012820

Where to get it

The cheapest GLP-1

Every seller that publishes a price, ordered lowest first on the standing month-to-month rate, plus the question to ask before you pay any of them.

See the board →

More in Evidence